(Q37558648)

21 August 2017

1 reference

title

Predicting outcome in melanoma: where are we now? (English)

1 reference

21 August 2017

L Jennings

1

1 reference

PubMed ID

19624540

21 August 2017

G M Murphy

series ordinal

2

1 reference

PubMed ID

19624540

21 August 2017

language of work or name

English

0 references

publication date

4 June 2009

1 reference

British Journal of Dermatology

21 August 2017

1 reference

21 August 2017

161

1 reference

21 August 2017

3

1 reference

21 August 2017

496-503

1 reference

Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity

21 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2009.09324.X

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2009.09324.X

The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2009.09324.X

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2009.09324.X

Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2009.09324.X

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/84635

Identifiers

DOI

10.1111/J.1365-2133.2009.09324.X

1 reference

21 August 2017

1 reference

PubMed ID

19624540